ARAAF vs. OVID

Last updated Jun 3, 2026

ARAAF (Aclara Resources Inc) and OVID (Ovid Therapeutics Inc.) are both stocks. ARAAF operates in Other Industrial Metals & Mining (Basic Materials), while OVID operates in Biotechnology (Healthcare). Over the past 3 years, ARAAF returned 114.62%/yr vs -13.16%/yr for OVID. At a 0.05 correlation, their price movements are largely independent.

Performance

ARAAF vs. OVID - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aclara Resources Inc (ARAAF) and Ovid Therapeutics Inc. (OVID). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ARAAF achieves a 119.06% return, which is significantly higher than OVID's 47.24% return.

ARAAF

• 1D: 8.81%
• 1M: -0.35%
• YTD: 119.06%
• 6M: 92.22%
• 1Y: 543.60%
• 3Y*: 114.62%
• 5Y*: —
• 10Y*: —

OVID

• 1D: -6.25%
• 1M: -13.98%
• YTD: 47.24%
• 6M: 53.85%
• 1Y: 727.87%
• 3Y*: -13.16%
• 5Y*: -11.21%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ARAAF vs. OVID - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ARAAF Aclara Resources Inc	119.06%	404.63%	-11.58%	49.59%	-78.68%	-7.97%
OVID Ovid Therapeutics Inc.	47.24%	74.57%	-71.00%	73.12%	-42.06%	1.90%

Correlation

The correlation between ARAAF and OVID is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.03
Correlation (All Time) Calculated using the full available price history since Dec 30, 2021	0.05

Fundamentals

Market Cap ARAAF : $763.12M OVID : $326.81M
EPS ARAAF : -$0.05 OVID : -$0.27
PB Ratio ARAAF : 5.03 OVID : 1.65
Total Revenue (TTM) ARAAF : $0.00 OVID : $7.12M
Gross Profit (TTM) ARAAF : -$1.03M OVID : $7.06M
EBITDA (TTM) ARAAF : -$9.35M OVID : -$47.25M

Return for Risk

ARAAF vs. OVID — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARAAF

ARAAF Risk / Return Rank: 95
ARAAF Sharpe Ratio Rank: 98
ARAAF Sortino Ratio Rank: 95
ARAAF Omega Ratio Rank: 92
ARAAF Calmar Ratio Rank: 97
ARAAF Martin Ratio Rank: 94

OVID

OVID Risk / Return Rank: 98
OVID Sharpe Ratio Rank: 99
OVID Sortino Ratio Rank: 97
OVID Omega Ratio Rank: 95
OVID Calmar Ratio Rank: 99
OVID Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARAAF vs. OVID - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aclara Resources Inc (ARAAF) and Ovid Therapeutics Inc. (OVID). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ARAAF	OVID	Difference
Sharpe ratio Return per unit of total volatility	4.75	6.48	-1.73
Sortino ratio Return per unit of downside risk	4.05	4.81	-0.76
Omega ratio Gain probability vs. loss probability	1.48	1.59	-0.10
Calmar ratio Return relative to maximum drawdown	9.19	22.47	-13.28
Martin ratio Return relative to average drawdown	18.92	56.57	-37.65
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ARAAF vs. OVID - Sharpe Ratio Comparison

The current ARAAF Sharpe Ratio is 4.75, which is comparable to the OVID Sharpe Ratio of 6.48. The chart below compares the historical Sharpe Ratios of ARAAF and OVID, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ARAAF	OVID	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	4.75	6.48	-1.73
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.14	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.23	-0.19	+0.42

Drawdowns

ARAAF vs. OVID - Drawdown Comparison

The maximum ARAAF drawdown since its inception was -84.58%, smaller than the maximum OVID drawdown of -98.30%. Use the drawdown chart below to compare losses from any high point for ARAAF and OVID.

Drawdown Indicators

	ARAAF	OVID	Difference
Max Drawdown Largest peak-to-trough decline	-84.58%	-98.30%	+13.72%
Max Drawdown (1Y) Largest decline over 1 year	-56.89%	-34.78%	-22.11%
Max Drawdown (3Y) Largest decline over 3 years	-56.89%	-93.69%	+36.80%
Max Drawdown (5Y) Largest decline over 5 years	—	-94.32%	—
Current Drawdown Current decline from peak	-9.42%	-84.00%	+74.58%
Average Drawdown Average peak-to-trough decline	-58.43%	-75.10%	+16.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	27.65%	13.82%	+13.83%

Volatility

ARAAF vs. OVID - Volatility Comparison

Aclara Resources Inc (ARAAF) has a higher volatility of 19.08% compared to Ovid Therapeutics Inc. (OVID) at 17.65%. This indicates that ARAAF's price experiences larger fluctuations and is considered to be riskier than OVID based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARAAF	OVID	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.08%	17.65%	+1.43%
Volatility (6M) Calculated over the trailing 6-month period	61.59%	58.76%	+2.83%
Volatility (1Y) Calculated over the trailing 1-year period	115.53%	113.47%	+2.06%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	118.75%	79.90%	+38.85%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	118.75%	85.73%	+33.02%

Dividends

ARAAF vs. OVID - Dividend Comparison

Neither ARAAF nor OVID has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ARAAF and OVID in my portfolio?

ARAAF and OVID have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ARAAF or OVID?

ARAAF has higher volatility (19.08%) compared to OVID (17.65%). In terms of maximum drawdown, ARAAF dropped -84.58% vs OVID's -98.30%.

Which has better risk-adjusted returns?

OVID currently has the higher Sharpe Ratio (6.48 vs 4.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.